Cargando…

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic

In 2022, we opened an outpatient clinic for the management of polypharmacy and potential drug–drug interactions (pDDIs) in patients with mycobacterial infection (called GAP-MyTB). All patients who underwent a GAP-MyTB visit from March 2022 to March 2023 were included in this retrospective analysis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cattaneo, Dario, Torre, Alessandro, Schiuma, Marco, Civati, Aurora, Lazzarin, Samuel, Rizzardini, Giuliano, Gori, Andrea, Antinori, Spinello, Gervasoni, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375959/ https://www.ncbi.nlm.nih.gov/pubmed/37508267 http://dx.doi.org/10.3390/antibiotics12071171

Ejemplares similares

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
por: Cattaneo, Dario, et al.
Publicado: (2020)

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
por: Cattaneo, Dario, et al.
Publicado: (2021)

Histoplasmosis Diagnosed in Europe and Israel: A Case Report and Systematic Review of the Literature from 2005 to 2020
por: Antinori, Spinello, et al.
Publicado: (2021)

Retinal vessels modifications in acute and post-COVID-19
por: Invernizzi, Alessandro, et al.
Publicado: (2021)

Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events
por: Gervasoni, Cristina, et al.
Publicado: (2013)

The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review
por: Cattaneo, Dario, et al.
Publicado: (2022)

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
por: Restelli, Umberto, et al.
Publicado: (2014)

Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate?
por: Giacomelli, Andrea, et al.
Publicado: (2021)

Management of diabetes mellitus in people living with HIV: A single-center experience
por: Cattaneo, Dario, et al.
Publicado: (2023)

The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
por: Nusair, Mohammad B., et al.
Publicado: (2020)

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
por: Restelli, Umberto, et al.
Publicado: (2017)

Retinal findings in patients with COVID-19: Results from the SERPICO-19 study
por: Invernizzi, Alessandro, et al.
Publicado: (2020)

Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out
por: Tagliabue, Mario, et al.
Publicado: (2021)

Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review
por: Borgonovo, Fabio, et al.
Publicado: (2023)

Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
por: Pezzati, Laura, et al.
Publicado: (2021)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
por: Das, Biswadeep, et al.
Publicado: (2020)

Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
por: Cattaneo, D., et al.
Publicado: (2021)

Invasive Fungal Infections Complicating COVID-19: A Narrative Review
por: Casalini, Giacomo, et al.
Publicado: (2021)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Targeting continuity of care and polypharmacy to reduce drug–drug interaction
por: Weng, Yi-An, et al.
Publicado: (2020)

Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
por: Bojuwoye, Adetola Olaniyi, et al.
Publicado: (2022)

Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012)

Polypharmacy - is there a cure for drug therapy problems?
por: Orehovački, Helena, et al.
Publicado: (2023)

Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
por: Dookeeram, Darren, et al.
Publicado: (2017)

New challenges in human monkeypox outside Africa: A review and case report from Italy
por: Mileto, Davide, et al.
Publicado: (2022)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2020)

Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy
por: Yazici, Esra, et al.
Publicado: (2017)

Hospitalisation for monkeypox in Milan, Italy
por: Moschese, Davide, et al.
Publicado: (2022)

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
por: Rodrigues, Maria Cristina Soares, et al.
Publicado: (2016)

Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
por: Albertsen, Nadja, et al.
Publicado: (2022)

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
por: Salamone, Sandro, et al.
Publicado: (2022)

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
por: Kilit, Türkan Paşalı, et al.
Publicado: (2022)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2021)

Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients
por: Das, Biswadeep, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m787n2cvsu327qqd75k4fsi181